WOBURN, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...
WOBURN, Mass. - Biofrontera Inc. (NASDAQ:BFRI) has successfully locked databases for two clinical studies evaluating its Ameluz photodynamic therapy (PDT) for actinic keratosis and acne vulgaris, the ...
Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026 Data generated will support key regulatory milestones for Ameluz PDT in both indications AK and acne ...
Shares of Baidu Inc (NASDAQ: BIDU) rose sharply in pre-market trading after the company announced its proposed spinoff and separate listing of the H shares of Kunlunxin (Beijing) Technology Co., Ltd.
Biopharma financing values have shown quarterly volatility over the past decade, with surges often concentrated in specific quarters rather than evenly distributed throughout the year. The pandemic ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results